Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00749
|
|||||
| Drug Name |
PRX-00023
|
|||||
| Synonyms |
740873-06-7; 833C676; AN-27536; Acetamide, N-(3-(4-(4-(((cyclohexylmethyl)sulfonyl)amino)butyl)-1-piperazinyl)phenyl)-; BCP20177; BDBM50187377; CHEMBL209821; CS-6740; D09358; HY-14848; L001689; LQ54E5B4EW; N-(3-[4-(4-Cyclohexylmethanesulfonylaminobutyl)piperazin-1-yl]phenyl)acetamide; N-[3-[4-[4-(cyclohexylmethylsulfonylamino)butyl]piperazin-1-yl]phenyl]acetamide; Naluzotan; Naluzotan (USAN/INN); Naluzotan [USAN:INN]; PRX 00023; PRX-00023; SB16847; SCHEMBL678016; UNII-LQ54E5B4EW; ZINC3963096
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C23H38N4O3S
|
|||||
| Canonical SMILES |
CC(=O)NC1=CC(=CC=C1)N2CCN(CC2)CCCCNS(=O)(=O)CC3CCCCC3
|
|||||
| InChI |
InChI=1S/C23H38N4O3S/c1-20(28)25-22-10-7-11-23(18-22)27-16-14-26(15-17-27)13-6-5-12-24-31(29,30)19-21-8-3-2-4-9-21/h7,10-11,18,21,24H,2-6,8-9,12-17,19H2,1H3,(H,25,28)
|
|||||
| InChIKey |
SPWZXWDPAWDKQE-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 740873-06-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 450.6 | Topological Polar Surface Area | 90.1 | ||
| Heavy Atom Count | 31 | Rotatable Bond Count | 10 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
3.2
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.